Tubal, Lady Jane C.
HRN: 26-54-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/25/2025
02/01/2025
IV
3g
Q6H
UTI; T/C Antibiotic Resistance
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes